The pharmaceutical – and especially the biopharmaceutical – industry doesn’t know any such thing as standstill. It is driven by ongoing research regarding new compounds and therapies, and the requirements in the laboratories and production facilities are changing accordingly.
With the growing demand for new drugs – not least triggered by the corona pandemic – and just in line with our generally fast-moving times, labs and manufacturers feel the pressure to deliver at a constantly accelerating pace while remaining flexible. While generally applicable standards must always be adhered to, labs and plants are expected to operate as cost-effectively as possible in all phases of process intensification process development and production.
In response to the changing requirements, more and more players are choosing an approach that is based on recyclable and extremely flexible single-use technologies. Novel processes such as seed train intensificatio by SUSupport are being implemented increasingly, utilizing lab and production systems that are based on single-use components. Single-use technologies and components are far more flexible and adaptable than conventional systems and stainless steel reactors.